Review on magnetic nanoparticle-mediated hyperthermia for cancer therapy
Source abstract
Abstract
Biocompatible magnetic nanoparticle-mediated magnetic hyperthermia is an innovative, efficient, and safer thermo-therapeutic approach for cancer treatment. Structural and magnetic properties of magnetic nanoparticles as well as external magnetic field parameters are responsible for a controlled heating performance imperative for clinical success. This review covers topics from the nanophysics of magnetic nanoparticles through the basic concepts of magnetism to the different magnetic nanoparticles used for magnetic hyperthermia. Relevant properties beneficial for magnetic hyperthermia including size (nanosize regime of 10–100 nm), shape (anisotropic and isotropic), viscosity of the dispersive medium, and applied magnetic field parameters to optimize the heat dissipation via various mechanisms are also addressed. Primary aim of the present review is to provide an interdisciplinary knowledge platform for the basic understanding of nanomagnetism in order to advance further in the field of nanomedicine. This review pinpoints recent advancements in nanoparticle-tumor tissue interactions and their translation to clinical applications. The present review differs from other contemporary reviews by reporting the up-to-date developments in the nanotechnology aspects of magnetic hyperthermia and addressing the future perspectives.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Abenojar EC, Wickramasinghe S, Bas-Concepcion J, Samia ACS (2016) Structural effects on the magnetic hyperthermia properties of iron oxide nanoparticles. Prog Nat Sci Mater Int 26:440–44810.1016/j.pnsc.2016.09.004 ↗
2. Albarqi HA, Wong LH, Schumann C, Sabei FY, Korzun T, Li X, Hansen MN, Dhagat P, Moses AS, Taratula O, Taratula O (2019) Biocompatible nanoclusters with high heating efficiency for systemically delivered magnetic hyperthermia. ACS Nano 13:6383–639510.1021/acsnano.8b06542 ↗
3. Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505–51510.1021/mp800051m ↗
4. Amaya-Jaramillo CD, Pérez-Portilla AP, Serrano-Olmedo JJ, Ramos-Gómez M (2017) Induction of cell death by magnetic particles in response to a gradient magnetic field inside a uniform magnetic field. J Nanopart Res 19:32910.1007/s11051-017-4018-0 ↗
5. Andersen HL, Christensen M (2015) In situ powder X-ray diffraction study of magnetic CoFe2O4 nanocrystallite synthesis. Nanoscale 7:3481–349010.1039/C4NR06937D ↗
6. Arami H, Khandhar A, Liggitt D, Krishnan KM (2015) In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev 44:8576–860710.1039/C5CS00541H ↗
7. Arends TJH, Nativ O, Maffezzini M, De Cobelli O, Canepa G, Verweij F, Moskovitz B, Van Der Heijden AG, Witjes JA (2016) Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus bacillus Calmette-Guerin for adjuvant treatment of patients with intermediate- and high-risk non-muscle-invasive bladder cancer. Eur Urol 69:1046–105210.1016/j.eururo.2016.01.006 ↗
8. Arteaga-Cardona F, Rojas-Rojas K, Costo R, Mendez-Rojas MA, Hernando A, De La Presa P (2016) Improving the magnetic heating by disaggregating nanoparticles. J Alloys Compd 663:636–64410.1016/j.jallcom.2015.10.285 ↗
9. Augustine S, Singh J, Srivastava M, Sharma M, Das A, Malhotra BD (2017) Recent advances in carbon based nanosystems for cancer theranostics. Biomater Sci 5:901–95210.1039/C7BM00008A ↗
10. Balivada S, Rachakatla RS, Wang H, Samarakoon TN, Dani RK, Pyle M, Kroh FO, Walker B, Leaym X, Koper OB, Tamura M, Chikan V, Bossmann SH, Troyer DL (2010) A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study. BMC Cancer 10:11910.1186/1471-2407-10-119 ↗
11. Barua S, Mitragotri S (2014) Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today 9:223–24310.1016/j.nantod.2014.04.008 ↗
12. Basu A, Kunduru KR, Abtew E, Domb AJ (2016) Correction to polysaccharide-based conjugates for biomedical applications. Bioconjug Chem 27:1427–142810.1021/acs.bioconjchem.6b00197 ↗
13. Bauer LM, Situ SF, Griswold MA, Samia ACS (2016) High-performance iron oxide nanoparticles for magnetic particle imaging – guided hyperthermia (hMPI). Nanoscale 8:12162–1216910.1039/C6NR01877G ↗
14. Belyanina I, Kolovskaya O, Zamay S, Gargaun A, Zamay T, Kichkailo A (2017) Targeted magnetic nanotheranostics of cancer. Molecules 22:97510.3390/molecules22060975 ↗
15. Berdov BA, Menteshashvili GZ (1990) Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperth 6:881–89010.3109/02656739009140970 ↗
16. Briceño S, Hernandez AC, Sojo J, Lascano L, Gonzalez G (2017) Degradation of magnetite nanoparticles in biomimetic media. J Nanopart Res 19:14010.1007/s11051-017-3800-3 ↗
17. Chamberlin RV, Humfeld KD, Farrell D, Yamamuro S, Ijiri Y, Majetich SA (2002) Magnetic relaxation of iron nanoparticles. J Appl Phys 91:6961–696310.1063/1.1452194 ↗
18. Chandra S, Das R, Kalappattil V, Eggers T, Harnagea C, Nechache R, Phan M-H, Rosei F, Srikanth H (2017) Epitaxial magnetite nanorods with enhanced room temperature magnetic anisotropy. Nanoscale 9:7858–786710.1039/C7NR01541K ↗
19. Chandunika RK, Vijayaraghavan R, Sahu NK (2018) MnFe2O4/CdSe magneto-fluorescent nanocomposite for possible biomedical applications. AIP Conf Proc 1942:05010210.1063/1.5028733 ↗
20. Chen R, Christiansen MG, Anikeeva P (2013) Maximizing hysteretic losses in magnetic ferrite nanoparticles via model-driven synthesis and materials optimization. ACS Nano 7:8990–900010.1021/nn4035266 ↗
21. Chen J, Liu J, Hu Y, Tian Z, Zhu Y (2019) Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release. Sci Technol Adv Mater 20:1043–105410.1080/14686996.2019.1682467 ↗
22. Chen B, Xing J, Li M, Liu Y, Ji M (2020) DOX@ ferumoxytol-medical chitosan as magnetic hydrogel therapeutic system for effective magnetic hyperthermia and chemotherapy in vitro. Colloids Surf B: Biointerfaces 190:11089610.1016/j.colsurfb.2020.110896 ↗
23. Chenthamara D, Subramaniam S, Ramakrishnan SG, Krishnaswamy S, Essa MM, Lin F-H, Qoronfleh MW (2019) Therapeutic efficacy of nanoparticles and routes of administration. Biomater Res 23:2010.1186/s40824-019-0166-x ↗
24. Chertok B, David AE, Yang VC (2010) Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials 31:6317–632410.1016/j.biomaterials.2010.04.043 ↗
25. Cho H-Y, Lee T, Yoon J, Han Z, Rabie H, Lee K-B, Su WW, Choi J-W (2018) Magnetic oleosome as a functional lipophilic drug carrier for cancer therapy. ACS Appl Mater Interfaces 10:9301–930910.1021/acsami.7b19255 ↗
26. Cole AJ, David AE, Wang J, Galbán CJ, Hill HL, Yang VC (2011) Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials 32:2183–219310.1016/j.biomaterials.2010.11.040 ↗
27. Colombo R, Salonia A, Leib Z, Pavone-Macaluso M, Engelstein D (2011) Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer. BJU Int 107:912–91810.1111/j.1464-410X.2010.09654.x ↗
28. Coombes RC (2015) Drug testing in the patient: toward personalized cancer treatment. Sci Transl Med 7:284ps1010.1126/scitranslmed.aab1214 ↗
29. Cruz MM, Ferreira LP, Ramos J, Mendo SG, Alves AF, Godinho M, Carvalho MD (2017) Enhanced magnetic hyperthermia of CoFe2O4 and MnFe2O4 nanoparticles. J Alloys Compd 703:370–38010.1016/j.jallcom.2017.01.297 ↗
30. Cullity BD, Graham CD (2008) Ferromagnetism. In: B.D. Cullity and C.D. Graham (ed) Introduction to magnetic materials, 2nd edn. Wiley, New York, pp 115–14910.1002/9780470386323 ↗
31. Dalal M, Greneche J-M, Satpati B, Ghzaiel TB, Mazaleyrat F, Ningthoujam RS, Chakrabarti PK (2017) Microwave absorption and the magnetic hyperthermia applications of Li0.3Zn0.3Co0.1Fe2.3O4 nanoparticles in multiwalled carbon nanotube matrix. ACS Appl Mater Interfaces 9:40831–4084510.1021/acsami.7b12091 ↗
32. Das R, Alonso J, Nemati Porshokouh Z, Kalappattil V, Torres D, Phan M-H, Garaio E, García JÁ, Sanchez Llamazares JL, Srikanth H (2016) Tunable high aspect ratio Iron oxide nanorods for enhanced hyperthermia. J Phys Chem C 120:10086–1009310.1021/acs.jpcc.6b02006 ↗
33. Das P, Colombo M, Prosperi D (2019) Recent advances in magnetic fluid hyperthermia for cancer therapy. Colloids Surf B: Biointerfaces 174:42–5510.1016/j.colsurfb.2018.10.051 ↗
34. Datta NR, Ordóñez SG, Gaipl US, Paulides MM, Crezee H, Gellermann J, Marder D, Puric E, Bodis S (2015) Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future. Cancer Treat Rev 41:742–75310.1016/j.ctrv.2015.05.009 ↗
35. Deatsch AE, Evans BA (2014) Heating efficiency in magnetic nanoparticle hyperthermia. J Magn Magn Mater 354:163–17210.1016/j.jmmm.2013.11.006 ↗
36. Dennis CL, Ivkov R (2013) Physics of heat generation using magnetic nanoparticles for hyperthermia. Int J Hyperth 29:715–72910.3109/02656736.2013.836758 ↗
37. Din FU, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A (2017) Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine 12:7291–730910.2147/IJN.S146315 ↗
38. Dormann JL, Fiorani D, Tronc E (1997) Magnetic relaxation in fine-particle systems. Adv Chem Phys:283–49410.1002/9780470141571.ch4 ↗
39. Dutz S, Hergt R, Mürbe J, Müller R, Zeisberger M, Andrä W, Töpfer J, Bellemann ME (2007) Hysteresis losses of magnetic nanoparticle powders in the single domain size range. J Magn Magn Mater 308:305–31210.1016/j.jmmm.2006.06.005 ↗
40. El-Sherbiny IM, Elbaz NM, Sedki M, Elgammal A, Yacoub MH (2017) Magnetic nanoparticles-based drug and gene delivery systems for the treatment of pulmonary diseases. Nanomedicine 12:387–40210.2217/nnm-2016-0341 ↗
41. Espinosa A, Bugnet M, Radtke G, Neveu S, Botton GA, Wilhelm C, Abou-Hassan A (2015) Can magneto-plasmonic nanohybrids efficiently combine photothermia with magnetic hyperthermia. Nanoscale 7:18872–1887710.1039/C5NR06168G ↗
42. Figuerola A, Di Corato R, Manna L, Pellegrino T (2010) From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharmacol Res 62:126–14310.1016/j.phrs.2009.12.012 ↗
43. Fortin J-P, Wilhelm C, Servais J, Ménager C, Bacri J-C, Gazeau F (2007) Size-sorted anionic Iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J Am Chem Soc 129:2628–263510.1021/ja067457e ↗
44. Gao H, Zhang T, Zhang Y, Chen Y, Liu B, Wu J, Liu X, Li Y, Peng M, Zhang Y, Xie G, Zhao F, Fan HM (2020) Ellipsoidal magnetite nanoparticles: a new member of the magnetic-vortex nanoparticles family for efficient magnetic hyperthermia. J Mater Chem B 8:515–52210.1039/C9TB00998A ↗
45. Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, Discher DE (2007) Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2:249–25510.1038/nnano.2007.70 ↗
46. Gogoi M, Sarma HD, Bahadur D, Banerjee R (2013) Biphasic magnetic nanoparticles–nanovesicle hybrids for chemotherapy and self-controlled hyperthermia. Nanomedicine 9:955–97010.2217/nnm.13.90 ↗
47. Gogoi M, Jaiswal MK, Sarma HD, Bahadur D, Banerjee R (2017) Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy. Integr Biol 9:555–56510.1039/C6IB00234J ↗
48. Gonzales-Weimuller M, Zeisberger M, Krishnan KM (2009) Size-dependant heating rates of iron oxide nanoparticles for magnetic fluid hyperthermia. J Magn Magn Mater 321:1947–195010.1016/j.jmmm.2008.12.017 ↗
49. Guardia P, Corato R, Lartigue L, Wilhelm C, Espinosa A, Garcia-Hernandez M, Gazeau F, Manna L, Pellegrino T (2012) Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment. ACS Nano 6:3080–309110.1021/nn2048137 ↗
50. Guisasola E, Asín L, Beola L, De La Fuente JM, Baeza A, Vallet-Regí M (2018) Beyond traditional hyperthermia: in vivo cancer treatment with magnetic-responsive mesoporous silica nanocarriers. ACS Appl Mater Interfaces 10:12518–1252510.1021/acsami.8b02398 ↗
51. Gustafson HH, Holt-Casper D, Grainger DW, Ghandehari H (2015) Nanoparticle uptake: the phagocyte problem. Nano Today 10:487–51010.1016/j.nantod.2015.06.006 ↗
52. Ha PT, Le TTH, Bui TQ, Pham HN, Ho AS, Nguyen LT (2019) Doxorubicin release by magnetic inductive heating and in vivo hyperthermia-chemotherapy combined cancer treatment of multifunctional magnetic nanoparticles. New J Chem 43:5404–541310.1039/C9NJ00111E ↗
53. Hayashi K, Moriya M, Sakamoto W, Yogo T (2009) Chemoselective synthesis of folic acid−functionalized magnetite nanoparticles via click chemistry for magnetic hyperthermia. Chem Mater 21:1318–132510.1021/cm803113e ↗
54. Hayashi K, Nakamura M, Miki H, Ozaki S, Abe M, Matsumoto T, Sakamoto W, Yogo T, Ishimura K (2014) Magnetically responsive smart nanoparticles for cancer treatment with a combination of magnetic hyperthermia and remote-control drug release. Theranostics 4:834–84410.7150/thno.9199 ↗
55. Hemery G, Keyes AC, Garaio E, Rodrigo I, Garcia JA, Plazaola F, Garanger E, Sandre O (2017) Tuning sizes, morphologies, and magnetic properties of monocore versus multicore iron oxide nanoparticles through the controlled addition of water in the polyol synthesis. Inorg Chem 56:8232–824310.1021/acs.inorgchem.7b00956 ↗
56. Hergt R, Dutz S, Röder M (2008) Effects of size distribution on hysteresis losses of magnetic nanoparticles for hyperthermia. J Phys Condensed Matter 20:38521410.1088/0953-8984/20/38/385214 ↗
57. Hirosawa F, Iwasaki T, Watano S (2017) Synthesis and magnetic induction heating properties of Gd-substituted Mg–Zn ferrite nanoparticles. Appl Nanosci 7:209–21410.1007/s13204-017-0566-y ↗
58. Hoshyar N, Gray S, Han H, Bao G (2016) The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine 11:673–69210.2217/nnm.16.5 ↗
59. Huang J, Bu L, Xie J, Chen K, Cheng Z, Li X, Chen X (2010) Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano 4:7151–716010.1021/nn101643u ↗
60. Hugounenq P, Levy M, Alloyeau D, Lartigue L, Dubois E, Cabuil V, Ricolleau C, Roux S, Wilhelm C, Gazeau F, Bazzi R (2012) Iron oxide monocrystalline nanoflowers for highly efficient magnetic hyperthermia. J Phys Chem C 116:15702–1571210.1021/jp3025478 ↗
61. Issa B, Obaidat IM, Albiss BA, Haik Y (2013) Magnetic nanoparticles: surface effects and properties related to biomedicine applications. Int J Mol Sci 14:21266–2130510.3390/ijms141121266 ↗
62. Issels RD, Abdel-Rahman S, Wendtner CM, Falk MH, Kurze V, Sauer H, Aydemir U, Hiddemann W (2001) Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. Eur J Cancer 37:1599–160810.1016/S0959-8049(01)00183-6 ↗
63. Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem B-C, Abdel-Rahman S, Daugaard S, Salat C, Wendtner C-M, Vujaskovic Z, Wessalowski R, Jauch K-W, Dürr HR, Ploner F, Baur-Melnyk A, Mansmann U, Hiddemann W, Blay J-Y, Hohenberger P (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11:561–57010.1016/S1470-2045(10)70071-1 ↗
64. Jeong U, Teng X, Wang Y, Yang H, Xia Y (2007) Superparamagnetic colloids: controlled synthesis and niche applications. Adv Mater 19:33–6010.1002/adma.200600674 ↗
65. Jeotikanta M, Meiying X, Julian B, Jacob E, Takele S, Sanjay M, Liu JP (2020) Enhancing the magnetic and inductive heating properties of Fe3O4 nanoparticles via morphology control. Nanotechnology 31:27570610.1088/1361-6528/ab84a3 ↗
66. Johannsen M, Gneveckow U, Eckelt L, Feussner A, Waldöfner N, Scholz R, Deger S, Wust P, Loening SA, Jordan A (2005) Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperth 21:637–64710.1080/02656730500158360 ↗
67. Jordan A, Scholz R, Wust P, Fak H, Felix R (1999) Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 201:413–41910.1016/S0304-8853(99)00088-8 ↗
68. Jordan A, Scholz R, Maier-Hauff K, Van Landeghem FKH, Waldoefner N, Teichgraeber U, Pinkernelle J, Bruhn H, Neumann F, Thiesen B, Von Deimling A, Felix R (2006) The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neuro-Oncol 78:7–1410.1007/s11060-005-9059-z ↗
69. Kafrouni L, Savadogo O (2016) Recent progress on magnetic nanoparticles for magnetic hyperthermia. Progress Biomater 5:147–16010.1007/s40204-016-0054-6 ↗
70. Kauffman KJ, Dorkin JR, Yang JH, Heartlein MW, Derosa F, Mir FF, Fenton OS, Anderson DG (2015) Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett 15:7300–730610.1021/acs.nanolett.5b02497 ↗
71. Khan A, Arunima Rajan S, Chandunika RK, Sahu NK (2019) Magneto-plasmonic stimulated breast cancer nanomedicine. In: N.D. Thorat and J.Bauer (ed) External Field and Radiation Stimulated Breast Cancer Nanotheranostics. IOP Publishing, US, pp 1–730627. https://doi.org/10.1088/2053-2563/ab290710.1088/2053-2563/ab2907 ↗
72. Khoshnevisan K, Poorakbar E, Baharifar H, Barkhi M (2019) Recent advances of cellulase immobilization onto magnetic nanoparticles: an update review. Magnetochemistry 5:3610.3390/magnetochemistry5020036 ↗
73. Khurshid H, Alonso Masa J, Nemati Z, Phan M-H, Mukherjee P, Fdez-Gubieda ML, Barandiarán J, Srikanth H (2015) Anisotropy effects in magnetic hyperthermia: a comparison between spherical and cubic exchange-coupled FeO/Fe3O4 nanoparticles. J Appl Phys 117:17A33710.1063/1.4919250 ↗
74. Kim Y-J, Ebara M, Aoyagi T (2013) A smart hyperthermia nanofiber with switchable drug release for inducing cancer apoptosis. Adv Funct Mater 23:5753–576110.1002/adfm.201300746 ↗
75. Kim H-C, Kim E, Jeong SW, Ha T-L, Park S-I, Lee SG, Lee SJ, Lee SW (2015) Magnetic nanoparticle-conjugated polymeric micelles for combined hyperthermia and chemotherapy. Nanoscale 7:16470–1648010.1039/C5NR04130A ↗
76. Kim D, Kim J, Park YI, Lee N, Hyeon T (2018) Recent development of inorganic nanoparticles for biomedical imaging. ACS Cent Sci 4:324–33610.1021/acscentsci.7b00574 ↗
77. Kitamura K, Kuwano H, Watanabe M, Nozoe T, Yasuda M, Sumiyoshi K, Saku M, Sugimachi K (1995) Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. J Surg Oncol 60:55–5810.1002/jso.2930600111 ↗
78. Knobel M, Nunes WC, Socolovsky LM, Biasi E, Vargas JM, Denardin JC (2008) Superparamagnetism and other magnetic features in granular materials: a review on ideal and real systems. J Nanosci Nanotechnol 6:2836–285710.1166/jnn.2008.15348 ↗
79. Kolhar P, Anselmo AC, Gupta V, Pant K, Prabhakarpandian B, Ruoslahti E, Mitragotri S (2013) Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc Natl Acad Sci 110:10753–1075810.1073/pnas.1308345110 ↗
80. Kossatz S, Grandke J, Couleaud P, Latorre A, Aires A, Crosbie-Staunton K, Ludwig R, Dähring H, Ettelt V, Lazaro-Carrillo A, Calero M, Sader M, Courty J, Volkov Y, Prina-Mello A, Villanueva A, Somoza Á, Cortajarena AL, Miranda R, Hilger I (2015) Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Res 17:66–6610.1186/s13058-015-0576-1 ↗
81. Kotoulas A, Dendrinou-Samara C, Sarafidis C, Kehagias T, Arvanitidis J, Vourlias G, Angelakeris M, Kalogirou O (2017) Carbon-encapsulated cobalt nanoparticles: synthesis, properties, and magnetic particle hyperthermia efficiency. J Nanopart Res 19:39910.1007/s11051-017-4099-9 ↗
82. Krishnan KM (2016) Magnetic materials: from isolated moments to ordered arrangements. Fundamentals and Applications of Magnetic Materials. Oxford University Press, Oxford
83. Kulshrestha P, Gogoi M, Bahadur D, Banerjee R (2012) In vitro application of paclitaxel loaded magnetoliposomes for combined chemotherapy and hyperthermia. Colloids Surf B: Biointerfaces 96:1–710.1016/j.colsurfb.2012.02.029 ↗
84. Kumar CSSR, Mohammad F (2011) Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv Drug Deliv Rev 63:789–80810.1016/j.addr.2011.03.008 ↗
85. Kumar S, Daverey A, Sahu NK, Bahadur D (2013) In vitro evaluation of PEGylated mesoporous MgFe2O4 magnetic nanoassemblies (MMNs) for chemo-thermal therapy. J Mater Chem B 1:3652–366010.1039/c3tb20429d ↗
86. Kumar S, Daverey A, Khalilzad-Sharghi V, Sahu NK, Kidambi S, Othman SF, Bahadur D (2015) Theranostic fluorescent silica encapsulated magnetic nanoassemblies for in vitro MRI imaging and hyperthermia. RSC Adv 5:53180–5318810.1039/C5RA07632C ↗
87. Lan S, Xie W, Wang J, Hu J, Tang W, Yang W, Yu X, Liu H (2018) PEGylated polyethylenimine-stabilized polypyrrole nanoparticles loaded with DOX for chemo-photothermal therapy of cancer cells. J Nanopart Res 20:30010.1007/s11051-018-4418-9 ↗
88. Laurent S, Dutz S, Häfeli UO, Mahmoudi M (2011) Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interf Sci 166:8–2310.1016/j.cis.2011.04.003 ↗
89. Le Renard P-E, Jordan O, Faes A, Petri-Fink A, Hofmann H, Rüfenacht D, Bosman F, Buchegger F, Doelker E (2010) The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia. Biomaterials 31:691–70510.1016/j.biomaterials.2009.09.091 ↗
90. Lee J-H, Jang J-T, Choi J-S, Moon SH, Noh S-H, Kim J-W, Kim J-G, Kim I-S, Park KI, Cheon J (2011) Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat Nanotechnol 6:418–42210.1038/nnano.2011.95 ↗
91. Lesiak B, Rangam N, Jiricek P, Gordeev I, Tóth J, Kövér L, Mohai M, Borowicz P (2019) Surface study of Fe3O4 nanoparticles functionalized with biocompatible adsorbed molecules. Front Chem 7:64210.3389/fchem.2019.00642 ↗
92. Liauw SL, Connell PP, Weichselbaum RR (2013) New paradigms and future challenges in radiation oncology: an update of biological targets and technology. Sci Transl Med 5:173sr210.1126/scitranslmed.3005148 ↗
93. Liu XL, Yang Y, Ng CT, Zhao LY, Zhang Y, Bay BH, Fan HM, Ding J (2015) Magnetic vortex nanorings: a new class of hyperthermia agent for highly efficient in vivo regression of tumors. Adv Mater 27:1939–194410.1002/adma.201405036 ↗
94. Liu X, Zhang Y, Wang Y, Zhu W, Li G, Ma X, Zhang Y, Chen S, Tiwari S, Shi K, Zhang S, Fan HM, Zhao YX, Liang X-J (2020) Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy. Theranostics 10:3793–381510.7150/thno.40805 ↗
95. Ma X, Wang Y, Liu X-L, Ma H, Li G, Li Y, Gao F, Peng M, Fan HM, Liang X-J (2019) Fe3O4–Pd Janus nanoparticles with amplified dual-mode hyperthermia and enhanced ROS generation for breast cancer treatment. Nanoscale Horizons 4:1450–145910.1039/C9NH00233B ↗
96. Mai T, Hilt JZ (2017) Magnetic nanoparticles: reactive oxygen species generation and potential therapeutic applications. J Nanopart Res 19:25310.1007/s11051-017-3943-2 ↗
97. Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, Von Deimling A, Waldoefner N, Felix R, Jordan A (2007) Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neuro-Oncol 81:53–6010.1007/s11060-006-9195-0 ↗
98. Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V, Jordan A (2011) Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neuro-Oncol 103:317–32410.1007/s11060-010-0389-0 ↗
99. Majumder P, Bhunia S, Chaudhuri A (2018) A lipid-based cell penetrating nano-assembly for RNAi-mediated anti-angiogenic cancer therapy. Chem Commun 54:1489–149210.1039/C7CC08517F ↗
100. Marchetti M, De Bei O, Bettati S, Campanini B, Kovachka S, Gianquinto E, Spyrakis F, Ronda L (2020) Iron metabolism at the interface between host and pathogen: from nutritional immunity to antibacterial development. Int J Mol Sci 21:214510.3390/ijms21062145 ↗